NCT04129541

Brief Summary

The purpose of this study is to determine the safety and acceptability of same-day discharge after surgery for pelvic floor disorders. The study hypotheses are that same-day discharge after reconstructive pelvic surgery is safe and improves patient satisfaction when compared to overnight hospitalization.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jul 2020

Typical duration for not_applicable

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 10, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 17, 2019

Completed
9 months until next milestone

Study Start

First participant enrolled

July 1, 2020

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2022

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2023

Completed
Last Updated

April 26, 2021

Status Verified

April 1, 2021

Enrollment Period

2.3 years

First QC Date

October 10, 2019

Last Update Submit

April 22, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in Quality of Recovery Score

    Quality of recovery will be assessed using the Quality of Recovery-15 (QoR-15) at baseline, 48 hours postop, and 6-8 weeks postop. The QoR-15 consists of 15 questions scored on a 0 to 10 scale, maximum score 150. Higher scores indicate good recovery after surgery while lower scores indicate poor recovery.

    6 to 8 weeks after surgery

  • Patient Satisfaction

    Patient satisfaction will be assessed using the Patient Global Impression of Improvement (PGI-I) at 6-8 weeks postop. The PGI-I consists of 1 question scored 1-7, with lower number indicating better global improvement.

    6 to 8 weeks after surgery

Secondary Outcomes (8)

  • Safety Measures: frequency of post operative complications

    Up to 8 weeks after surgery

  • Quality of Recovery (baseline)

    Baseline

  • Quality of Recovery (48 hours)

    48 hours postop

  • Quality of Recovery (at postop visit)

    48 hours postop

  • Pelvic Floor Distress (baseline)

    Baseline

  • +3 more secondary outcomes

Study Arms (2)

SDD

ACTIVE COMPARATOR

Patients will receive routine care during their admission for surgery. A standard voiding trial will be performed in the PACU for all patients. Patients in the planned same day discharge (SDD) cohort will be discharged from the PACU once they meet standard discharge criteria.

Other: Same Day Discharge

OH

ACTIVE COMPARATOR

Patients will receive routine care during their admission for surgery. A standard voiding trial will be performed in the PACU for all patients. Patients in the planned overnight hospitalization (OH) group will be discharged on post-operative day 1 once they meet standard discharge criteria.

Other: Overnight Hospitalization

Interventions

Patients in the planned same day discharge (SDD) cohort will be discharged from the PACU once they meet standard discharge criteria.

SDD

Patients in the planned overnight hospitalization (OH) group will be discharged on post-operative day 1 once they meet standard discharge criteria.

OH

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing surgery for pelvic organ prolapse, with or without concomitant hysterectomy or incontinence procedure.

You may not qualify if:

  • Patients undergoing concomitant non-gynecologic procedure
  • The presence of: gynecologic malignancy, American Society of Anesthesiologists (ASA) class \>2, severe cardiovascular or pulmonary comorbidities, prior anesthesia complication, or obstructive sleep apnea
  • Anyone living alone with no family/friend/caretaker to assist the patient on day of surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Oz Harmanli, MD

    Chief, Yale Urogynecology and Pelvic Reconstructive Surgery

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 10, 2019

First Posted

October 17, 2019

Study Start

July 1, 2020

Primary Completion

October 31, 2022

Study Completion

April 30, 2023

Last Updated

April 26, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will not share